Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AZD5863 |
Synonyms | |
Therapy Description |
AZD5863 is a bispecific T-cell engager targeting CLDN18.2 and CD3, which potentially induces T-cell dependent cellular cytotoxicity and tumor growth inhibition (J ImmunoTherapy Cancer 2023;11 (Suppl_1):1169). |